Deal-making news last week included US drug developer KalVista Pharma signing a licensing agreement with Kaken Pharma to market its investigational hereditary angioedema (HAE) drug sebetralstat in ...

Sun Pharmaceutical Industries stock ended 2.15 per cent higher on Friday after zooming by almost 5 per cent in the morning ...

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

Indian drugmaker Sun (BSE: 524715) shares were buzzing in trade on the last trading day of the week to April 11, rising as ...

The US Court of Appeals for the Federal Circuit vacated a preliminary injunction on Leqselvi’s launch, lifting restrictions ...

Emkay Global Financial Services, in a client note, described the development as “materially positive,” as it removes a key ...

Emkay Global maintains a 'Buy' rating on Sun Pharma after the US Court of Appeals vacates the injunction against Leqselvi's ...

Sun Pharmaceutical Industries on Thursday said that it has received a major relief from a US court, which allowed it to ...

Drugmaker Sun Pharma on Thursday said the U.S. Court of Appeals for the Federal Circuit has vacated a preliminary injunction effective immediately that thus far restricted the company from launching ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

On Thursday, April 10, Sun Pharma announced that the U.S. Court of Appeals for the Federal Circuit has vacated a preliminary ...

Delhi: In a major relief to Sun Pharmaceutical Industries Ltd, the U.S. Court of Appeals for the Federal Circuit has vacated ...